PROCEPT BioRobotics Corporation Common Stock (PRCT)
How it compares with the broader market is one of its lowest-scoring factors, with smart-money score is above the middle.
PRCT scores higher than 49% of the 1,101 tickers we compare it with (Health Care).
As of 9 October 2026, PROCEPT BioRobotics Corporation Common Stock (PRCT) scores 39 out of 100 on the Market Census six-factor composite, which puts it at the Below average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 0.87× 30-day average
- 52-week range
- 16.66 – 38.11
- Market cap
- $1.11B
- Earnings date
- 29 Oct 2026
- Volume
- 1,113,857
- Avg. volume (30d)
- 1,285,115
- Open
- 17.78
- Previous close
- 17.90
- Day's range (regular session)
- 17.78 – 18.44
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- 0.90
- P/E (TTM)
- —
- EPS (TTM)
- -1.95
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
Premium data held for PRCT
- 9 SEC Form 4 insider transactions in the last 90 daysPremium
Counts of rows Market Census holds for PRCT. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans
What the score says about PRCT right now
PROCEPT BioRobotics Corporation Common Stock (PRCT) currently scores 39/100 on the Market Census six-factor composite, at the Below average score level. PRCT is +2.79% on the day and +6.41% over five sessions as of the most recent tick. Below average sits a bit below the middle. More of PRCT's data reads poorly than well. The level is a "look before you act" flag. It is not advice. PRCT's strongest factor is insider trades at 87/100 — a very strong read on insider buying and selling. Insider filings currently lean toward buying on this name — a plain read of public filings, not a signal to follow. The weakest factor is strength vs the market at 7/100 — well below average next to the wider market.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See PRCT in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent PRCT news
Latest headlines that name PROCEPT BioRobotics, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- Does New Director and Discounting Lawsuit Change The Bull Case For PROCEPT BioRobotics (PRCT)?Yahoo
- LAWSUIT ALERT: Investors who lost money with PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares should contact the Shareholders FoundationGlobeNewswire Inc.
- Important Notice to Long-Term Shareholders of Doximity, Inc. (NYSE: DOCS); GoDaddy Inc. (NYSE: GDDY); Planet Fitness, Inc. (NYSE: PLNT); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswire Inc.
- Deadline Alert: PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud LawsuitGlobeNewswire Inc.
- Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Seeking Recovery to Contact the Firm Before September 22, 2026GlobeNewswire Inc.
We hide 2 more that told readers to buy or sell, or gave a price target.
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Health Care right now
Six health care tickers whose composite scores are closest to PRCT’s 39, all within 1 point.
Sorted by closeness to PRCT’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.